Medical Advocates
BMS-790052

Main Page

New and Noteworthy
Journal Data
Conference Data

ARV Investigational Drugs Main Page

Main New/Newsworthy

Home Page

Last Update: March 11, 2015

Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

March 2012

2012 CROI

Assessment of HIV ARV Drug Interactions with the HCV NS5A Replication Complex Inhibitor BMS-790052 Demonstrates a Pharmacokinetic Profile which Supports Co-administration with Tenofovir Disoproxil Fumarate, Efavirenz, and Atazanavir/ritonavir
Marc Bifano C Hwang, B Oosterhuis, et al

Journal Papers, Abstracts, and Commentaries

Multiple ascending dose study of BMS-790052, an NS5A replication complex inhibitor, in patients infected
with hepatitis C virus genotype 1.
Nettles RE, Gao M, Bifano M, et al
Hepatology. 2011 Aug 11
Abstract

Conference Reports

Assessment of HIV ARV Drug Interactions with the HCV NS5A Replication Complex Inhibitor BMS-790052 Demonstrates a Pharmacokinetic Profile which Supports Co-administration with Tenofovir Disoproxil Fumarate, Efavirenz, and Atazanavir/ritonavir
Marc Bifano C Hwang, B Oosterhuis, et al
(19 CROI)
Abstract

ARV Investigational Drugs Main Page Main New/Newsworthy Home Page

BMS-790052